APA (7th ed.) Citation

R, D., C, O., & JB, R. (2025). Noradrenergic therapies in neurodegenerative disease: From symptomatic to disease modifying therapy? Brain communications, 7(5), fcaf310. https://doi.org/10.1093/braincomms/fcaf310

Chicago Style (17th ed.) Citation

R, Durcan, O'Callaghan C, and Rowe JB. "Noradrenergic Therapies in Neurodegenerative Disease: From Symptomatic to Disease Modifying Therapy?" Brain Communications 7, no. 5 (2025): fcaf310. https://doi.org/10.1093/braincomms/fcaf310.

MLA (9th ed.) Citation

R, Durcan, et al. "Noradrenergic Therapies in Neurodegenerative Disease: From Symptomatic to Disease Modifying Therapy?" Brain Communications, vol. 7, no. 5, 2025, p. fcaf310, https://doi.org/10.1093/braincomms/fcaf310.